Hormonal regulation of renal multidrug resistance-associated proteins 3 and 4 (Mrp3 and Mrp4) in mice

Biochemical Pharmacology
Jonathan M MaherCurtis D Klaassen

Abstract

Multidrug resistance-associated proteins 3 and 4 (Mrp3 and Mrp4) are expressed at much higher levels in female than male kidney. Sex steroids and sex-specific growth hormone (GH) secretion patterns often mediate gender-predominant gene expression. Thus, three models were used to investigate potential endocrine regulation of Mrp3 and Mrp4: (1) gonadectomized (GNX) mice with 17beta-estradiol (E2) or 5alpha-dihydroxytestosterone (DHT) replacement; (2) hypophysectomized (HPX) mice receiving E2, DHT, or simulated male-pattern (MP) or female-pattern (FP) GH secretion; (3) lit/lit mice, which have a spontaneous mutation in the growth-hormone releasing-hormone (GHRH) receptor, with simulated MP- or FP-GH secretion. GNX and HPX decreased Mrp3 mRNA levels compared with intact females. In both respective models E2 administration increased Mrp3 expression in GNX and HPX mice. DHT markedly repressed Mrp3 from GNX+placebo levels, however, this was not observed in the HPX model. In lit/lit mice, Mrp3 expression was lower than in wild-type controls, and MP-GH and FP-GH simulation slightly increased Mrp3 expression. Whereas GNX increased Mrp4 in males to female levels, HPX actually increased Mrp4 expression in both genders +375% and +66%, respe...Continue Reading

References

Jan 1, 1976·Neuroendocrinology·A SaundersJ B Martin
Dec 1, 1991·The Journal of Endocrinology·J N MacLeodB H Shapiro
Aug 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·D J WaxmanB H Shapiro
Feb 10, 1989·Cell·M Beato
Jan 1, 1987·Ophthalmic Research·M C NgN J Unakar
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L S MathewsR D Palmiter
Jul 1, 1983·Journal of Steroid Biochemistry·J A GustafssonG Norstedt
Oct 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A KimuraM Tohma
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·N Varin-BlankT Meo
Jan 25, 2000·The Journal of Biological Chemistry·T HirohashiY Sugiyama
Oct 3, 2001·The Journal of Biological Chemistry·N ZelcerP Borst
Feb 22, 2002·Journal of the American Society of Nephrology : JASN·Rémon A M H van AubelFrans G M Russel
Mar 7, 2002·Chemico-biological Interactions·Naomi KudoYoichi Kawashima
Dec 10, 2002·Biochemical and Biophysical Research Communications·Hidetaka AkitaYuichi Sugiyama
Apr 16, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Susan C N BuistCurtis D Klaassen
Jul 29, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maria RiusDietrich Keppler
Jan 21, 2004·Journal of Gastroenterology and Hepatology·Makoto KurodaYukihiko Adachi
Feb 24, 2004·Molecular Pharmacology·Jixiang MaDarryl C Zeldin
Mar 30, 2004·Biochemical and Biophysical Research Communications·Chuan Chen, Curtis D Klaassen
May 25, 2004·Molecular Endocrinology·Christopher A WiwiDavid J Waxman
Aug 18, 2004·Molecular and Cellular Biology·Markos LeggasJohn D Schuetz
Mar 3, 2005·World Journal of Gastroenterology : WJG·Li-Zong ShenWen-Xi Wu
Apr 2, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jonathan M MaherCurtis D Klaassen

❮ Previous
Next ❯

Citations

Jan 10, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·David B Buckley, Curtis D Klaassen
Aug 15, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xingguo Cheng, Curtis D Klaassen
Mar 27, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Zidong Donna FuCurtis D Klaassen
Aug 17, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Lindsay L YacovinoLauren M Aleksunes
Jan 28, 2010·Pharmacological Reviews·Curtis D Klaassen, Lauren M Aleksunes
Nov 5, 2010·American Journal of Physiology. Renal Physiology·Maggie K Diamond-StanicHeddwen L Brooks
Nov 3, 2012·Therapeutic Advances in Medical Oncology·Clara Hwang
Sep 11, 2012·The AAPS Journal·Rosalinde Masereeuw, Frans G M Russel
Apr 26, 2012·Toxicology Letters·Lindsay L Yacovino, Lauren M Aleksunes
Aug 31, 2012·Journal of Biochemical and Molecular Toxicology·Lindsay L Yacovino, Lauren M Aleksunes
Apr 24, 2012·Journal of Applied Toxicology : JAT·Jeffrey C SivilsLisa J Bain
Jun 20, 2015·Clinical Pharmacology and Therapeutics·K L R BrouwerUNKNOWN Pediatric Transporter Working Group
Nov 19, 2013·Toxicology and Applied Pharmacology·Zidong Donna Fu, Curtis D Klaassen
Oct 24, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Amy M BatailleJ Larry Renfro
Mar 19, 2013·Virchows Archiv : an International Journal of Pathology·Matteo MontaniGlen Kristiansen
Mar 15, 2013·Bulletin of Experimental Biology and Medicine·M I AleksandrovaO V Smirnova
Sep 22, 2017·Current Medicinal Chemistry·Juan Pablo RigalliJohanna Weiss
Jul 8, 2015·The Journal of Pharmacology and Experimental Therapeutics·Jiagen WenWei Zhang
Apr 7, 2020·Expert Opinion on Drug Metabolism & Toxicology·Jenna L Yager, Peter L Anderson
Mar 3, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ruud BuetersKendall S Frazier
Oct 22, 2020·International Journal of Molecular Sciences·Catarina LopesMário Dinis-Ribeiro
Aug 8, 2020·Ecotoxicology and Environmental Safety·Esther U KadieneSami Souissi
Aug 26, 2010·Molecular Pharmaceutics·Anne Mahringer, Gert Fricker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

© 2021 Meta ULC. All rights reserved